Clincosm LogoSign in Get a demo

Solid Tumor

Showing NaN - NaN of 94
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Solid Tumor Trial in Worldwide (BEZ235 + MEK162)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Solid Tumor
  • BEZ235 + MEK162
  • Boston, Massachusetts
  • +5 more
Oct 7, 2020

Solid Tumor, Breast Cancer, Colon Cancer Trial in Worldwide (LY3039478, Taladegib, Abemaciclib)

Completed
  • Solid Tumor
  • +4 more
  • Miami, Florida
  • +10 more
Aug 13, 2020

Solid Tumor, Lymphoma, Peripheral T-Cell Lymphoma Trial in United States (ALRN-6924)

Completed
  • Solid Tumor
  • +2 more
  • Birmingham, Alabama
  • +12 more
Jul 13, 2020

Cancer, Ovarian Cancer, Solid Tumor Trial in United States (IT-101 (12mg/m2/dose), IT-101 (15mg/m2/dose), 5% Dextrose (Placebo))

Withdrawn
  • Cancer
  • +2 more
  • IT-101 (12mg/m2/dose)
  • +2 more
  • Decatur, Illinois
  • +6 more
Jun 10, 2020

Advanced Cancer, Solid Tumor Trial in Houston (Vemurafenib, Everolimus, Temsirolimus)

Completed
  • Advanced Cancer
  • Solid Tumor
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 1, 2020

Solid Tumor, HER-2 Protein Overexpression Trial in United States (ACTR T Cell Product, Trastuzumab)

Terminated
  • Solid Tumor
  • HER-2 Protein Overexpression
  • New Haven, Connecticut
  • +5 more
Mar 27, 2020

Solid Tumor Trial in Worldwide (Atezolizumab)

Terminated
Has Results
  • Solid Tumor
  • Little Rock, Arkansas
  • +29 more
Feb 24, 2020

Metastatic Cancer, Cancer, Solid Tumor Trial in Sunnyvale, New York, Houston (BP31510 monotherapy, BP31510 in combination with

Completed
  • Metastatic Cancer
  • +2 more
  • BP31510 monotherapy
  • BP31510 in combination with chemotherapy
  • Sunnyvale, California
  • +2 more
Nov 7, 2019

Solid Tumor Trial in Chicago, Saint Louis, Houston (AP-002)

Unknown status
  • Solid Tumor
  • Chicago, Illinois
  • +2 more
Oct 30, 2019

Solid Tumor Trial in Canada, United States (Cetuximab, Carboplatin, 5 - FU)

Completed
Has Results
  • Solid Tumor
  • Fayetteville, Arkansas
  • +7 more
Sep 10, 2019

Solid Tumor, Hematologic Malignancies Trial in United States (BGJ398)

Terminated
Has Results
  • Solid Tumor
  • Hematologic Malignancies
  • Birmingham, Alabama
  • +55 more
May 28, 2019

Solid Tumor Trial in United States (MSC2363318A, MSC2363318A plus Trastuzumab, MSC2363318A plus Tamoxifen)

Completed
  • Solid Tumor
  • Birmingham, Alabama
  • +14 more
Sep 18, 2018

Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS Trial in

Completed
  • Advanced Malignancies
  • +4 more
  • Orange, California
  • +5 more
Jun 27, 2016

Neoplastic Meningitis, Solid Tumor, Lymphoma Trial in Houston (RTA 744)

Terminated
  • Neoplastic Meningitis
  • +4 more
  • RTA 744
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
May 12, 2016

Solid Tumor, Lymphoma Trial in Denmark, United Kingdom, United States (oral belinostat)

Completed
  • Solid Tumor
  • Lymphoma
  • oral belinostat
  • New Haven, Connecticut
  • +5 more
Jul 7, 2015

Cancer, Solid Tumor Trial in United States (IMC-1121B, Moxifloxacin, Diphenhydramine)

Completed
Has Results
  • Cancer
  • Solid Tumor
  • IMC-1121B
  • +2 more
  • Atlanta, Georgia
  • +6 more
May 15, 2015

Solid Tumor, Thyroid Cancer Trial in Houston (Capecitabine (Xeloda), DTIC-Dome (Dacarbazine), Gleevec (Imatinib Mesylate))

Terminated
  • Solid Tumor
  • Thyroid Cancer
  • Capecitabine (Xeloda)
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 16, 2014

Advanced Cancer, Solid Tumor Trial in Nashville, Houston (OPB-31121)

Completed
  • Advanced Cancer
  • Solid Tumor
  • Nashville, Tennessee
  • +1 more
Feb 11, 2013

Hematologic Malignancy, Solid Tumor Trial in Houston (Voraxaze (Glucarpidase), Placebo)

Terminated
Has Results
  • Hematologic Malignancy
  • Solid Tumor
  • Voraxaze (Glucarpidase)
  • Placebo
  • Houston, Texas
    U.T. M.D. Anderson Cancer Center
Dec 4, 2012